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phenotypic traits and disorders in dogs. The canine P2RX7 gene, coding the ATP-gated P2X7 receptor ion 
channel, contains four known missense variants. The current study aimed to examine the presence of 
these variants in a random sample of pedigree and mixed-pedigree dogs. Exons 3, 8, 11 and 13 of the 
P2RX7 gene, encoding these four respective variants, in 65 dogs were assessed by Sanger sequencing 
and combined with existing sequencing data from another 69 dogs. The distribution of these variants was 
then evaluated in all 134 dogs combined and separately within individual breeds including 35 different 
pure breeds. The rs23314713 (p.Phe103Leu) and rs23315462 (p.Pro452Ser) variants were present in 47 
and 40% of all dogs studied respectively, with the rs23314713 variant associated with brachycephalic 
breeds. Among pedigree dogs, the rs23314713 and rs23315462 variants were associated with 
brachycephalic and non-brachycephalic breeds respectively. The rs851148233 (p.Arg270Cys) and 
rs850760787 (p.Arg365Gln) variants were present only in dogs of Cocker Spaniel and Labrador Retriever 
pedigrees respectively. No other missense variants were found in exons 3, 8, 11 and 13 of the P2RX7 
gene within the dogs. In conclusion, the rs23314713 and rs23315462 missense variants of the P2RX7 
gene are present in a large proportion of dogs, with the rs23314713 variant associated with a number of 
brachycephalic breeds. However, the association of this variant with dogs of bulldog ancestry, not 
brachycephaly per se, cannot be excluded. 
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Missense variants are associated with various phenotypic traits and disorders in dogs. The canine 
P2RX7 gene, coding the ATP-gated P2X7 receptor ion channel, contains four known missense 
variants. The current study aimed to examine the presence of these variants in a random sample of 
pedigree and mixed-pedigree dogs. Exons 3, 8, 11 and 13 of the P2RX7 gene, encoding these four 
respective variants, in 65 dogs were assessed by Sanger sequencing and combined with existing 
sequencing data from another 69 dogs. The distribution of these variants was then evaluated in all 
134 dogs combined and separately within individual breeds including 35 different pure breeds. The 
rs23314713 (p.Phe103Leu) and rs23315462 (p.Pro452Ser) variants were present in 47% and 40% 
of all dogs studied, respectively, with the rs23314713 variant associated with brachycephalic 
breeds. Among pedigree dogs, the rs23314713 and rs23315462 variants were associated with 
brachycephalic and non-brachycephalic breeds, respectively. The rs851148233 (p.Arg270Cys) and 
rs850760787 (p.Arg365Gln) variants were present only in dogs of Cocker Spaniel and Labrador 
Retriever pedigree, respectively. No other missense variants were found in exons 3, 8, 11 and 13 of 
the P2RX7 gene within the dogs. In conclusion, the rs23314713 and rs23315462 missense variants 
of the P2RX7 gene are present in a large proportion of dogs, with the rs23314713 variant associated 
with a number of brachycephalic breeds. However, the association of this variant with dogs of 
bulldog ancestry, not brachycephaly per se, cannot be excluded. 
 
Keywords P2X7 receptor, purinergic receptor, single nucleotide polymorphism, DH82 canine 
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The P2X7 receptor is a trimeric ATP-gated cation channel encoded by the P2RX7 gene (Sluyter 
2017). The P2X7 receptor has important roles in inflammation, immunity and cancer (Di Virgilio et 
al. 2017). In dogs, the P2X7 receptor is present on monocytes, lymphocytes, erythrocytes (Sluyter 
et al. 2007; Stevenson et al. 2009), kidney epithelial cells (Jalilian et al. 2012b; Zuccarini et al. 
2017) and neurons of the myenteric plexus (Schafer et al. 2018). This receptor is also present in 
normal brain tissue including the cerebrum (Lee et al. 2005; Truve et al. 2016), and in 
glioblastomas, oligodendrogliomas and astrocytomas (Truve et al. 2016) from dogs. Canine P2X7 
receptor activation results in interleukin-1 release from monocytes (Jalilian et al. 2012a) and in 
whole blood (Roman et al. 2009; Spildrejorde et al. 2014b; Bartlett et al. 2017). Moreover, P2X7 
receptor activation results in phosphatidylserine exposure and hemolysis in canine erythrocytes 
(Sluyter et al. 2007; Faulks et al. 2016). Other cellular functions of the canine P2X7 receptor are 
yet to be reported, but its activation is likely to mediate events similar to those shown in humans, 
where it is an emerging therapeutic target in various disorders such as inflammatory bowel disease, 
osteoporosis, inflammatory pain and cancer (De Marchi et al. 2016). 
In a cohort of 69 dogs including 68 blood samples and MDCK cells (derived from a Cocker 
Spaniel), we previously identified four missense variants in the canine P2RX7 gene: rs23314713 
(p.Phe103Leu), rs851148233 (p.Arg270Cys), rs850760787 (p.Arg365Gln) and rs23315462 
(p.Pro452Ser) (Spildrejorde et al. 2014a). Another group subsequently found that the rs23314713 
variant is associated with susceptibility to glioma (Truve et al. 2016), a disease more frequent in 
several brachycephalic breeds (Hayes et al. 1975; Snyder et al. 2006; Song et al. 2013). 
Brachycephaly in dogs results in the shortening of the muzzle, flat facial conformation and 
widening of the skull, and includes breeds such as the Bulldog, Mastiff and Staffordshire Bull 
Terrier (Bannasch et al. 2010; Schoenebeck et al. 2012; Packer et al. 2015; Marchant et al. 2017). 
To extend these findings, the presence of the four previously described missense variants was 
evaluated in an additional 65 dogs. This data was then combined with existing data (Spildrejorde et 
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al. 2014a) to determine the distribution of these variants in a random sample of the canine 
population. 
Dog samples were collected in accordance with the Animal and Human Ethics Committees 
(University of Wollongong). Peripheral blood, drawn into VACUETTE lithium heparin tubes 
(Greiner Bio-One), was collected from 64 dogs presented at local veterinary clinics with informed 
consent from pet owners. DH82 cells (derived from a Golden Retriever) were obtained from the 
European Collection of Cell Cultures. These 65 samples including DH82 cells combined with our 
previously published cohort of 69 dogs (Spildrejorde et al. 2014a) represent 97 pedigree dogs 
(comprising 35 different pure breeds) and 37 mixed-pedigree dogs (Table S1). The veterinarians in 
consultation with pet owners assigned the breed of each dog. Pedigree dogs were classified as 
brachycephalic as reported in other studies (Bannasch et al. 2010; Schoenebeck et al. 2012; Packer 
et al. 2015; Marchant et al. 2017). Mixed-pedigree dogs were assigned as brachycephalic based on 
known ancestry and/or display of brachycephalic characteristics (shortening of the muzzle, flat 
facial conformation and widening of the skull). No dogs suffered from glioma at the time of 
presentation and were not followed up for this cancer post sampling. 
DNA was isolated using the Wizard Genomic DNA Purification Kit (Promega) according to 
the manufacturer’s instructions. Primer pairs (Table S2) were used to amplify and sequence exons 
3, 8 and 11 and the first half of exon 13 of the canine P2RX7 gene by PCR as described 
(Spildrejorde et al. 2014a). No other exons of the P2RX7 gene were sequenced. Resulting 
sequences were compared to the NCBI Reference Sequence NM_001113456.1, which is from a 
non-disclosed pedigree. Notably, the alleles in the reference sequence, for each of the four missense 
variants, are conserved across various mammalian species (Jiang et al. 2013). For some dogs, not 
all exons could be amplified or sequenced despite repeated attempts and successfully achieving this 
with other exons from the same DNA sample (Table S1). This resulted in different dog numbers 
being reported below for each exon studied. Differences in heterozygosity, homozygosity, variant 
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prevalence and mutant allele frequency between groups were compared by the Fisher’s Exact test 
using Prism 5 for Mac OS X (GraphPad Software, San Diego, CA, USA) with P < 0.05 considered 
significant. P-value calculations for prevalence include heterozygous and homozygous dog numbers 
combined. P-value calculations for allele frequency include total allele numbers. Analyses did not 
correct for relatedness of breeds. 
Sequence analysis of genomic DNA isolated from 65 new dogs combined with existing 
sequence data from another 69 dogs (Spildrejorde et al. 2014a) revealed (in decreasing order) a 
variant prevalence of 47%, 40%, 4% and 3% and a mutant allele frequency of 0.38, 0.26, 0.02 and 
0.02 for rs23314713 (p.Phe103Leu), rs23315462 (p.Pro452Ser), rs850760787 (p.Arg365Gln) and 
rs851148233 (p.Arg270Cys), respectively (Table 1; Table S1). A similar prevalence and allele 
frequency for each variant were also observed among pedigree dogs only (Table 1; Table S1). 
Linkage disequilibrium analysis (https://www.broadinstitute.org/haploview/haploview) revealed 
that none of the alleles were in strong linkage disequilibrium (results not shown), with the strongest 
association observed between rs23314713 and rs23315462 (D’ = 0.605 and r
2
 = 0.088). 
The combined data from pedigree and mixed-pedigree dogs revealed the presence of the 
rs23314713 (p.Phe103Leu) variant in 76% of brachycephalic dogs and 31% of non-brachycephalic 
dogs (Table 2), which differed significantly between these two groups (P < 0.0001). The allele 
frequencies of the rs23314713 mutant allele were 0.65 and 0.23 in brachycephalic and non-
brachycephalic dogs, respectively (Table 2), and also differed significantly between the two groups 
(P < 0.0001). Among pedigree dogs only, the prevalence (P < 0.0001) and allele frequency (P < 
0.0001) for this variant were also significantly greater in brachycephalic dogs compared to non-
brachycephalic dogs (Table 2). Moreover, there was a significantly higher proportion of 
brachycephalic dogs heterozygous for the rs23314713 variant compared to non-brachycephalic dog 
among all dogs (P = 0.0136) and pedigree dogs only (P = 0.0323). Likewise, there was a 
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significantly higher proportion of brachycephalic dogs homozygous for this variant compared to 
non-brachycephalic dog among all dogs (P < 0.0001) and pedigree dogs only (P < 0.0001). 
Collectively, the data above indicates that the rs23314713 variant is associated with dogs of 
brachycephalic pedigree. However, a second possibility is that this variant is associated with dogs 
of known bulldog ancestry including the Australian bulldog, American Staffordshire terrier and the 
Staffordshire terrier (Ostrander et al. 2017) not brachycephaly per se. In support of this, the three 
bull terriers studied, defined as non-brachycephalic dogs and which have bulldog ancestry 
(vonHoldt et al. 2010), were all homozygous for the rs23314713 variant. Whilst, four of the five 
Maltese Shih Tzu studied, defined as brachycephalic dogs and which do not have bulldog ancestry 
(vonHoldt et al. 2010), were homozygous for the reference allele at this position. Thus, it remains 
to be determined if the rs23314713 variant contributes to brachycephaly, but observations in mice 
do not support this. Despite well-established roles for P2X7 activity in bone formation and 
homeostasis (Agrawal & Gartland 2015), strains of mice with a loss-of-function P2RX7 missense 
variant (Syberg et al. 2012) or global ablation of the P2RX7 gene (Ke et al. 2003) do not display 
facial or skull differences, akin to brachycephaly, compared to mice with normal P2X7 activity. 
It should also be noted that our study, compared to others, is relatively small and represents 
limited breeds. A study of 576 dogs (representing 62 breeds) identified a missense variant 
(p.Phe452Leu) in BMP3, which codes for bone morphogenetic protein 3, is associated with 
cranioskeletal features of brachycephalic dogs (Schoenebeck et al. 2012). Whilst another study of 
375 dogs (representing 83 breeds) revealed that a retrotransposon-mediated missplicing of SMOC2, 
which encodes SPARC-related modular calcium-binding protein 2 is associated with brachycephaly 
(Marchant et al. 2017). Both of these proteins have potential roles in bone formation, but how the 
related genetic variations contribute to brachycephaly remains to be determined (Schoenebeck et al. 
2012; Marchant et al. 2017). 
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The combined data from pedigree and mixed-pedigree dogs revealed the presence of the 
second most common variant, rs23315462 (p.Pro452Ser), in 28% of brachycephalic dogs and 47% 
of non-brachycephalic dogs (Table 2), a difference which approached statistical significance (P = 
0.0650). The allele frequencies of the rs23315462 mutant allele were 0.19 and 0.31 in 
brachycephalic and non-brachycephalic dogs, respectively (Table 2), a difference which also 
approached statistical significance (P = 0.0547). Notably, among pedigree dogs, the prevalence (P 
= 0.0141) and allele frequency (P = 0.0124) for this variant were significantly greater in non-
brachycephalic dogs compared to brachycephalic dogs (Table 2). Collectively, this data revealed 
that the rs23315462 variant is potentially more prevalent in non-brachycephalic dogs compared to 
brachycephalic dogs. This difference mirrors the greater prevalence of the rs23314713 variant in 
brachycephalic dogs, which can be explained by incomplete linkage disequilibrium between these 
two alleles (Table S1). 
Although case numbers were small among all pedigree and mixed-pedigree dogs combined, 
the current data suggests that the rs851148233 (p.Arg270Cys) and rs850760787 (p.Arg365Gln) 
variants are limited to dogs of Cocker Spaniel and Labrador Retriever pedigree, respectively (Table 
S3). The rs851148233 variant was present in four dogs of Cocker Spaniel pedigree (two Cocker 
Spaniels, one Cavalier King Charles Spaniel and Cocker Spaniel cross, and one Cocker Spaniel and 
Poodle cross), but absent in three dogs of Cocker Spaniel pedigree (two Cocker Spaniels and one 
Poodle and Cocker Spaniel cross). The rs851148233 variant was also absent in two Cavalier King 
Charles Spaniels, one Maltese and Poodle cross and another 111 dogs of non-Cocker Spaniel 
pedigree. The rs850760787 variant was present in four Labrador Retriever and one Golden 
Retriever and Labrador Retriever cross. This variant was absent in six other Labrador Retrievers 
and another 119 dogs of non-Labrador Retriever pedigree including four Golden Retrievers. 
The current study did not reveal any new missense variants in the P2RX7 gene in any of the 
dogs sequenced (results not shown). This data contrasts the large polymorphic variation observed in 
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the human P2RX7 gene (De Marchi et al. 2016). Although the possibility remains that other 
missense variants are present in the remaining exons not sequenced, the limited polymorphic 
variation of the canine P2RX7 gene compared to the human P2RX7 gene is consistent with genome-
wide decreases in genetic variation as a result of population bottlenecks associated with 
domestication, local population history and breed creation (Ostrander et al. 2017). Finally, it should 
be noted that occasional exons could not be amplified or sequenced despite successfully achieving 
this with other exons from the same DNA sample. This may be due to sequence variations within 
the PCR primer binding sites, which were largely intronic, negatively impacting annealing or 
extension. 
In conclusion, the main finding of this study is that the rs23314713 (p.Phe103Leu) and 
rs23315462 (p.Pro452Ser) variants of the P2RX7 gene are commonly present in dogs, with the 
rs23314713 variant associated with a number of brachycephalic breeds, however the association of 
this variant with dogs of bulldog ancestry, not brachycephaly per se, cannot be excluded. 
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Table 1 Prevalence and allele frequency of P2RX7 gene missense variants.
 
   Genotype (n of dogs)   
Variant Amino acid 
change 








All dogs        
rs23314713 p.Phe103Leu 117 62 20 35 47% 0.38 
rs851148233 p.Arg270Cys 121 117 4 0 3% 0.02 
rs850760787 p.Arg365Gln 130 125 5 0 4% 0.02 
rs23315462 p.Pro452Ser 106 64 28 14 40% 0.26 
Pedigree 
dogs 
       
rs23314713 p.Phe103Leu 88 51 9 27 41% 0.36 
rs851148233 p.Arg270Cys 89 87 2 0 2% 0.01 
rs850760787 p.Arg365Gln 93 89 4 0 4% 0.02 
rs23315462 p.Pro452Ser 79 48 21 10 39% 0.26 
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Table 2 Prevalence and allele frequency of the rs23314713 (p.Phe103Leu) and rs23315462 
(p.Pro452Ser) variants in brachycephalic and non-brachycephalic dogs.
 
   Genotype (n of dogs)   












Yes 42 10 9a 23b 76%c 0.65d 
 No 75 52 11 12 31% 0.23 
rs23314713 
(pedigree dogs) 
Yes 28 6 4e 18b 79%c 0.71d 
 No 60 46 5 9 23% 0.19 
        
rs23315462 (all 
dogs) 
Yes 40 29 7 4 28% 0.19 
 No 66 35 21 10 47% 0.31 
rs23315462 
(pedigree dogs) 
Yes 26 21 3f 2 19%g 0.13h 
 No 53 27 18 8 49% 0.32 
aP = 0.0136 compared to proportion of heterozygous non-brachycephalic dogs (excludes homozygous dogs). 
bP < 0.0001 compared to proportion of homozygous non-brachycephalic dogs (excludes heterozygous dogs). 
cP < 0.0001 compared to prevalence in non-brachycephalic dogs. 
dP < 0.0001 compared to allele frequency in non-brachycephalic dogs. 
eP = 0.0323 compared to proportion of heterozygous non-brachycephalic dogs (excludes homozygous dogs). 
fP = 0.0269 compared to proportion of heterozygous non-brachycephalic dogs (excludes homozygous dogs). 
gP  = 0.0141 compared to prevalence in non-brachycephalic dogs. 
hP = 0.0124 compared to allele frequency in non-brachycephalic dogs. 




Table S1 Distribution of P2RX7 gene missense variants in a random sample of dogs. 
Table S2 Primers used to amplify and sequence missense variants of the canine P2RX7 gene. 
Table S3 Prevalence and allele frequency of the rs851148233 (p.Arg270Cys) and rs850760787 
(p.Arg365Gln) variants in dogs of Cocker Spaniel and Labrador Retriever pedigree, respectively. 
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Table S1 Distribution of P2RX7 gene missense variants in a random sample of dogs. 
     
Exon 3 Exon 8 Exon 11 Exon 13 
     
rs23314713 rs851148233 rs850760787 rs23315462 
Breed Pedigree Cladea Brachycephalicb Sexc p.Phe103Leu p.Arg270Cys p.Arg365Gln p.Pro452Ser 
Alaskan Malamute Yes Asian Spitz No M wt wt wt P/S 
Alaskan Malamute Yes Asian Spitz No MN wt wt wt P/S 




wt wt P/S 
American Bulldog cross Bull Arab cross Greyhound No 
 
Yes M wt wt wt wt 
American Staffordshire Terrier Yes European Mastiff Yes M F/L wt wt P/S 
American Staffordshire Terrier Yes European Mastiff Yes F F/L wt wt wt 
American Staffordshire Terrier Yes European Mastiff Yes F L/L wt wt wt 
American Staffordshire Terrier Yes European Mastiff Yes 
 
L/L wt wt wt 
American Staffordshire Terrier Yes European Mastiff Yes F 
 
wt wt 
 Australian Bulldog Yes European Mastiff Yes F L/L wt wt wt 
Australian Bulldog Yes European Mastiff Yes M L/L wt wt wt 
Australian Bulldog Yes European Mastiff Yes M wt wt wt 
 Australian Cattle Dog Yes UK Rural No M F/L wt wt P/S 
Australian Cattle Dog and Kelpie cross No 
 
No M wt 
 
wt 
 Basenji Yes Not determined No MN wt wt wt wt 
Beagle Yes Scent Hound No M wt wt wt S/S 
Beagle Yes Scent Hound No M wt wt wt wt 
Beagle Yes Scent Hound No F wt wt 
 
wt 





Table S1 cont.         
     
Exon 3 Exon 8 Exon 11 Exon 13 
     
rs23314713 rs851148233 rs850760787 rs23315462 
Breed Pedigree Cladea Brachycephalicb Sexc p.Phe103Leu p.Arg270Cys p.Arg365Gln p.Pro452Ser 
Border Collie Yes UK Rural No F wt wt wt P/S 
Border Collie Yes UK Rural No F wt wt wt wt 
Border Collie Yes UK Rural No FN wt wt wt 
 Border Collie Yes UK Rural No M wt 
 
wt 
 Border Collie and Australian Cattle Dog cross No 
 
No M wt wt wt wt 




wt wt wt 
British Bulldog Yes European Mastiff Yes F L/L wt wt wt 
Bull Arab Yes 
 
No M F/L wt wt wt 
Bull Terrier Yes European Mastiff No FN L/L wt wt wt 
Bull Terrier Yes European Mastiff No M L/L wt wt wt 
Bull Terrier (miniature) Yes European Mastiff No FN L/L wt wt wt 
Bull Terrier cross No 
 
No MN F/L wt wt wt 
Bullmastiff cross No 
 
Yes FN wt wt wt wt 
Cavalier King Charles Spaniel Yes Spaniel Yes 
 
L/L wt wt wt 
Cavalier King Charles Spaniel Yes Spaniel Yes M wt wt wt S/S 
Cavalier King Charles Spaniel and Cocker Spaniel cross No 
 
Yes M wt R/C wt S/S 
Chihuahua and Dachshund (miniature) cross No 
 
Yes M F/L wt wt wt 
Cocker Spaniel Yes Spaniel No 
 
wt R/C wt wt 
Cocker Spaniel Yes Spaniel No F wt wt wt wt 
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Table S1 cont.         
     
Exon 3 Exon 8 Exon 11 Exon 13 
     
rs23314713 rs851148233 rs850760787 rs23315462 
Breed Pedigree Cladea Brachycephalicb Sexc p.Phe103Leu p.Arg270Cys p.Arg365Gln p.Pro452Ser 
Cocker Spaniel Yes Spaniel No M wt wt wt wt 
Cocker Spaniel Yes Spaniel No MN wt 
   Cocker Spaniel Yes Spaniel No MN 
  
wt 
 Cocker Spaniel (MDCK cells) Yes Spaniel No F wt R/C wt P/S 
Cocker Spaniel and Poodle cross No 
 
No M wt R/C wt S/S 
Corgi cross No 
 
No FN F/L wt wt P/S 
Dachshund Yes Scent Hound No FN wt wt wt wt 
Dachshund (miniature) Yes Scent Hound No FN L/L wt wt S/S 
Dachshund (miniature) Yes Scent Hound No M L/L wt wt S/S 
Dachshund (miniature) Yes Scent Hound No FN wt wt wt S/S 
Dachshund (miniature) Yes Scent Hound No MN wt wt wt S/S 





 Fox Terrier (miniature) Yes American Terrier No MN F/L wt wt P/S 
Fox Terrier (miniature) Yes American Terrier No F F/L wt wt wt 
Fox Terrier (miniature) Yes American Terrier No F wt wt wt P/S 
German Shepherd Dog Yes New World No M L/L wt wt 
 German Shepherd Dog Yes New World No FN wt wt wt wt 
German Shepherd Dog Yes New World No FN wt wt wt 
 German Shepherd Dog cross No 
 
No F F/L wt wt 
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Table S1 cont.         
     
Exon 3 Exon 8 Exon 11 Exon 13 
     
rs23314713 rs851148233 rs850760787 rs23315462 
Breed Pedigree Cladea Brachycephalicb Sexc p.Phe103Leu p.Arg270Cys p.Arg365Gln p.Pro452Ser 
German Shorthaired Pointer Yes Pointer Setter No F wt wt wt S/S 
Golden Retriever Yes Retriever No F wt wt wt P/S 
Golden Retriever Yes Retriever No M wt wt wt 
 Golden Retriever Yes Retriever No FN 
 
wt wt 
 Golden Retriever (DH82 cells) Yes Retriever No M wt 
 
wt wt 
Golden Retriever and Labrador Retriever cross No 
 
No M L/L wt R/Q wt 
Hungarian Vizsla Yes Not determined No F wt wt wt wt 
Jack Russell Terrier Yes Terrier No F L/L wt wt wt 
Jack Russell Terrier Yes Terrier No F wt wt wt P/S 
Jack Russell Terrier cross No 
 
No F L/L wt wt wt 
Jack Russell Terrier cross No 
 
No MN L/L wt wt wt 
Jack Russell Terrier cross No 
 
No F wt wt wt wt 
Kelpie Yes UK Rural No M wt wt wt wt 
Kelpie Yes UK Rural No M 
 
wt wt P/S 
Labrador Retriever Yes Retriever No F F/L wt wt wt 
Labrador Retriever Yes Retriever No F L/L wt wt wt 
Labrador Retriever Yes Retriever No F L/L wt wt 
 Labrador Retriever Yes Retriever No F wt wt R/Q P/S 
Labrador Retriever Yes Retriever No F wt wt R/Q P/S 
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Table S1 cont.         
     
Exon 3 Exon 8 Exon 11 Exon 13 
     
rs23314713 rs851148233 rs850760787 rs23315462 
Breed Pedigree Cladea Brachycephalicb Sexc p.Phe103Leu p.Arg270Cys p.Arg365Gln p.Pro452Ser 
Labrador Retriever Yes Retriever No F wt wt R/Q wt 
Labrador Retriever Yes Retriever No F wt wt wt P/S 
Labrador Retriever Yes Retriever No M wt wt wt P/S 
Labrador Retriever Yes Retriever No M wt wt wt wt 
Labrador Retriever Yes Retriever No F 
 
wt R/Q S/S 
Maltese Yes Poodle No F wt wt wt wt 
Maltese Yes Poodle No M wt wt wt wt 
Maltese Yes Poodle No MN wt wt wt 
 Maltese Yes Poodle No FN wt 
 
wt wt 





 Maltese and Poodle cross No 
 
No F F/L wt wt wt 
Maltese cross No 
 
No MN F/L wt wt 










 Maltese Shih Tzu Yes Poodle/Asian Toy Yes M F/L 
   Maltese Shih Tzu Yes Poodle/Asian Toy Yes FN wt wt wt P/S 
Maltese Shih Tzu Yes Poodle/Asian Toy Yes M wt wt wt P/S 
Maltese Shih Tzu Yes Poodle/Asian Toy Yes F wt wt wt S/S 
Maltese Shih Tzu Yes Poodle/Asian Toy Yes MN wt wt wt wt 
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Table S1 cont.         
     
Exon 3 Exon 8 Exon 11 Exon 13 
     
rs23314713 rs851148233 rs850760787 rs23315462 
Breed Pedigree Cladea Brachycephalicb Sexc p.Phe103Leu p.Arg270Cys p.Arg365Gln p.Pro452Ser 
Mastiff and American Staffordshire Bull Terrier cross No 
 
Yes M L/L wt wt wt 
Newfoundland Yes Retriever No MN 
 
wt wt wt 
Pitbull Terrier Yes Not determined No F wt wt wt 
 Pomeranian Yes Small Spitz No FN wt wt wt 
 Poodle and Cocker Spaniel cross No 
 
No M wt wt wt S/S 
Pug and Beagle cross No 
 
Yes F L/L wt wt S/S 
Pug and Pomeranian cross No 
 
Yes M F/L wt wt P/S 
Rhodesian Ridgeback Yes European Mastiff No F wt wt wt P/S 
Rhodesian Ridgeback and Australian Cattle Dog cross No 
 
No MN wt wt wt wt 
Rottweiler Yes Drover No F wt wt wt S/S 










 Schnauzer Yes Schnauzer No M wt wt wt wt 
Schnauzer (miniature) and Bulldog cross No 
 
No FN F/L wt wt P/S 
Shar-Pei Yes Asian Spitz No M wt wt wt P/S 
Shih Tzu and Pug cross No 
 
Yes M wt wt wt 
 Siberian Husky  Yes Asian Spitz No F wt wt wt P/S 
Siberian Husky  Yes Asian Spitz No F wt wt wt P/S 
Staffordshire Bull Terrier Yes European Mastiff Yes M F/L wt wt wt 
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Table S1 cont.         
     
Exon 3 Exon 8 Exon 11 Exon 13 
     
rs23314713 rs851148233 rs850760787 rs23315462 
Breed Pedigree Cladea Brachycephalicb Sexc p.Phe103Leu p.Arg270Cys p.Arg365Gln p.Pro452Ser 
Staffordshire Bull Terrier Yes European Mastiff Yes F L/L wt wt wt 
Staffordshire Bull Terrier Yes European Mastiff Yes F L/L wt wt wt 
Staffordshire Bull Terrier Yes European Mastiff Yes F L/L wt wt wt 
Staffordshire Bull Terrier Yes European Mastiff Yes F L/L wt wt wt 
Staffordshire Bull Terrier Yes European Mastiff Yes F L/L wt wt wt 
Staffordshire Bull Terrier Yes European Mastiff Yes F L/L wt wt wt 
Staffordshire Bull Terrier Yes European Mastiff Yes F L/L wt wt wt 
Staffordshire Bull Terrier Yes European Mastiff Yes F L/L wt wt wt 
Staffordshire Bull Terrier Yes European Mastiff Yes FN L/L wt wt wt 
Staffordshire Bull Terrier Yes European Mastiff Yes MN L/L wt wt wt 
Staffordshire Bull Terrier Yes European Mastiff Yes 
 
L/L wt wt wt 
Staffordshire Bull Terrier Yes European Mastiff Yes F L/L 
   Staffordshire Bull Terrier Yes European Mastiff Yes F 
 
wt wt wt 
Staffordshire Bull Terrier Yes European Mastiff Yes 
  
wt wt 
 Staffordshire Bull Terrier and Kelpie cross No 
 
Yes F F/L wt wt wt 
Staffordshire Bull Terrier cross No 
 
Yes F F/L wt wt P/S 
Staffordshire Bull Terrier cross No 
 
Yes FN F/L wt wt P/S 
Staffordshire Bull Terrier cross No 
 
Yes F L/L wt wt P/S 
Staffordshire Bull Terrier cross No 
 
Yes F L/L wt wt wt 
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Table S1 cont.         
     
Exon 3 Exon 8 Exon 11 Exon 13 
     
rs23314713 rs851148233 rs850760787 rs23315462 
Breed Pedigree Cladea Brachycephalicb Sexc p.Phe103Leu p.Arg270Cys p.Arg365Gln p.Pro452Ser 
Staffordshire Bull Terrier cross No 
 
Yes F L/L wt wt wt 
aPedigree dogs were assigned into clades according to Parker et al. (2017). 
bMixed-pedigree dogs were assigned as brachycephalic based on known ancestry and/or display of brachycephalic characteristics (shortening of the muzzle, flat facial conformation and 
widening of the skull). Only one breed could be assigned in some dogs of mixed-pedigree when the ancestry of a cross was not fully known or could not be ascertained by visual observation. 
cSex: F, female; FN, neutered female; M, male; MN, neutered male. 
Empty fields indicate sex unknown or exons not sequenced.
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Table S2 Primers used to amplify and sequence missense variants of the canine P2RX7 gene.
 




AGTCCAAGTTGCTCCCAGAC GAGGACAGAAGAGGGAAAAGA 3 rs23314713 63.1oC 349 bp 
TTTAATCTGCGTTCCCCTCT AAGCCTTTTGCATTCATCTTG 8 rs851148233 63.1oC 368 bp 
CTCACTAACTCGCACTGAT TGATTTTGGCCTTATTTTTGC 11 rs850760787 62.2oC 262 bp 
GAACCTTAGGGGTGGTCACT CAAGCTCAGGTGCAAACAAA 13a rs23315462 64.1oC 600 bp 




Table S3 Prevalence and allele frequency of the rs851148233 (p.Arg270Cys) and rs850760787 
(p.Arg365Gln) variants in dogs of Cocker Spaniel and Labrador Retriever pedigree, respectively.
 
   Genotype (n of dogs)   










rs851148233 Cocker Spaniel 7a 3 4 0 57%b 0.29b 
 Non-Cocker 
Spaniel 
114c 114 0 0 0% 0 
rs850760787 Labrador 
Retriever 
11d 6 5 0 45%e 0.23e 
 Non-Labrador 
Retriever 
119f 119 0 0 0% 0 
aIncludes four Cocker Spaniels, one Cavalier King Charles Spaniel and Cocker Spaniel cross, one Cocker Spaniel and Poodle cross, 
and one Poodle and Cocker Spaniel cross. 
bP < 0.0001 compared to non-cocker Spaniels. 
cIncludes two Cavalier King Charles Spaniels, and one Maltese and Poodle cross. 
dIncludes 10 Labrador Retrievers, and one Golden Retriever and Labrador Retriever cross. 
eP < 0.0001 compared to non-Labrador Retrievers. 
fIncludes four Golden Retrievers. 
All statistical comparisons by Fisher’s Exact test. 
 
 
